BUPRENORPHINE HCL SUBLINGUAL TABLETS

BUPRENORPHINE HCL SUBLINGUAL TABLETS

  • Capsule & Tablet

Overview

NDC #
Strength
Product/Case Size
NDC #
00121-1019-30
Strength
2 mg
Product/Case Size
30 ct/48 cs
NDC #
00121-2038-30
Strength
8 mg
Product/Case Size
30 ct/48 cs
00121-1019-30
2 mg
30 ct/48 cs
00121-2038-30
8 mg
30 ct/48 cs

Wholesale Ordering

NDC #
Cardinal
Cencora
McKesson
Morris Dickson
NDC #
00121-1019-30
Cardinal
5876958
Cencora
10283244
McKesson
2862944
Morris Dickson
TBD
NDC #
00121-2038-30
Cardinal
5876966
Cencora
10283270
McKesson
2862977
Morris Dickson
TBD
00121-1019-30
5876958
10283244
2862944
TBD
00121-2038-30
5876966
10283270
2862977
TBD

Barcodes

NDC #
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-1019-30
GTIN Product Barcode
GTIN Case Barcode
NDC #
00121-2038-30
GTIN Product Barcode
GTIN Case Barcode
00121-1019-30
00121-2038-30
Download Barcode Brochure

Key Info

Compared to: SUBUTEX®

Free From:

Alcohol, dye, sugar

Rx or OTC:

Rx

Flavor:

N/A

Storage & Handling:

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Indications:

The treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support.

Please see full Prescribing Information for more information.